Managers / Q1 2024 · view latest →
Invenomic Capital Management LP
CIK 0001769456 · 211 CONGRESS STREET, 8TH FLOOR, BOSTON, MA, 02110 · 617-912-4972
Reported Value
$1.9B
Q1 2024
Positions
145
Filings on Record
26
2019–present window
Filed
May 15, 2024
original filing
Summary
Invenomic Capital Management Lp reported $1.9B in U.S.-listed holdings across 145 positions for Q1 2024.
Its largest position, CHRD, represents 3.0% of the portfolio.
Compared with Q4 2023, the fund opened 35 new positions and exited 62.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 85.0% · $1.6B
- Other · 10.3% · $193M
- ADR · 2.1% · $39M
- MLP · 1.4% · $26M
- REIT · 1.2% · $23M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.2B | 150 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.1B | 147 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.1B | 143 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.8B | 148 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.0B | 172 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.1B | 159 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.8B | 142 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.1B | 158 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.9B | 145 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.2B | 172 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.4B | 146 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.0B | 134 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.8B | 140 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.47T | 140 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.2B | 146 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.4B | 147 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $937M | 154 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $468M | 142 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $308M | 119 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $418M | 124 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $448M | 121 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $392M | 142 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $182M | 141 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $135M | 152 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $122M | 153 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $249M | 127 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.